Skip to main content
. 2022 Mar 2;22:205. doi: 10.1186/s12879-022-07210-y

Table 1.

Baseline characteristics of patients according to the clinical presentation at the emergency department

Total, n = 348 Explicit n = 245 Vague n = 103 OR 95% CI P
Demographics
 Age, median year (IQR) 70.6 (50–90) 71.1 (52–90) 1.00 0.98–1.02 0.72
 Gender female (%) 98 (40) 32 (31) 0.68 0.41–1.10 0.12
 Smoke (%) 75 (30.6) 34 (33) 1.12 0.68–1.83 0.66
 Alcohol (%) 47 (19.2) 28 (27,2) 1.57 0.92–2.69 0.09
Underlying diseases
 Hypertension (%) 121 (49.4) 59 (57.3) 1.37 0.86–2.19 0.18
 CHF (%) 47 (19.2) 19 (18.4) 0.95 0.53–1.72 0.87
 Myocardial infarction (%) 49 (20) 24 (23.3) 1.22 0.69–2.11 0.49
 Atrial fibrillation (%) 77 (31.4) 35 (34) 1.12 0.69–1.83 0.64
 PAOD (%) 33 (13.5) 24 (23.3) 1.95 0.09–3.51 0.025
 DVT (%) 27 (11) 10 (9.7) 1.95 1.09–3.51 0.72
 Diabetes mellitus (%) 76 (31) 29 (28.2) 0.87 0.53–1.45 0.59
 COPD (%) 34 (13.9) 18 (17.5) 1.31 0.70–2.45 0.39
 Asthma (%) 17 (6.9) 1 (1) 0.13 0.02–1.00 0.05
 CKD (%) 36 (14.7) 19 (18.5) 1.31 0.71–2.42 0.38
 Stroke (%) 19 (7.8) 14 (13.6) 1.87 0.89–3.89 0.09
 Neurocognitive disease (%) 18 (7.3) 10 (9.7) 1.35 0.60–3-05 0.46
 Cirrhosis (%) 18 (7.3) 6 (5.8) 0.78 0.30–2.03 0.61
 Immunosuppressive drugs (%) 43 (17.6) 12 (11.6) 0.62 0.31–1.23 0.17
 Haematological malignancy (%) 37 (15.1) 7 (6.8) 0.41 0.18–0.95 0.03
 Solid cancer (%) 56 (22.9) 25 (24.3) 1.08 0.63–1.86 0.78
Infection site
 Pneumonia (%) 117 (47.8) 52 (50.5) 1.12 0.70–1.77 0.64
 Urinary tract infection (%) 53 (21.6) 14 (13.6) 0.57 0.30–1.08 0.08
 SST infection (%) 16 (6.5) 4 (3.9) 0.58 0.19–1.77 0.34
 GI source of infection (%) 14 (5.7) 6 (5.8) 1.02 0.38–2.73 0.97
 Biliary source of infection (%) 7 (2.9) 10 (9.7) 3.66 1.35–9.89 0.01
 Bacteremia (%) 91 (37.1) 26 (25.2) 0.57 0.34–0.96 0.03

ED, Emergency Department; OR, Odds Ratio; CI, Confidence Interval; CHF, Chronic Heart Failure; PAOD, Peripheral Arterial Occlusive Disease; DVT, Deep Venous Thrombosis; COPD, Chronic Obstructive Pulmonary Disease; CKD, Chronic Kidney Disease; SST, Skin and Soft Tissues; GI, Gastrointestinal; IQR, Inter Quartile Range